These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32933356)

  • 21. Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs.
    Santamaria A; Alibrandi A; Di Benedetto A; Pintaudi B; Corrado F; Facchinetti F; D'Anna R
    Am J Obstet Gynecol; 2018 Sep; 219(3):300.e1-300.e6. PubMed ID: 29859136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship Between Myo-Inositol Supplementary and Gestational Diabetes Mellitus: A Meta-Analysis.
    Zheng X; Liu Z; Zhang Y; Lin Y; Song J; Zheng L; Lin S
    Medicine (Baltimore); 2015 Oct; 94(42):e1604. PubMed ID: 26496267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myo-inositol, D-chiro-inositol, folic acid and manganese in second trimester of pregnancy: a preliminary investigation.
    Malvasi A; Casciaro F; Minervini MM; Kosmas I; Mynbaev OA; Pacella E; Monti Condesnitt V; Creanza A; Di Renzo GC; Tinelli A
    Eur Rev Med Pharmacol Sci; 2014; 18(2):270-4. PubMed ID: 24488919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple-micronutrient supplementation for women during pregnancy.
    Haider BA; Bhutta ZA
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD004905. PubMed ID: 26522344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of Myo-inositol on fertility rates in poor ovarian responder in women undergoing assisted reproductive technique: a randomized clinical trial.
    Mohammadi S; Eini F; Bazarganipour F; Taghavi SA; Kutenaee MA
    Reprod Biol Endocrinol; 2021 Apr; 19(1):61. PubMed ID: 33892722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of myo-inositol supplementation on the prevention of gestational diabetes in overweight pregnant women: a randomized, double-blind, controlled trial.
    Esmaeilzadeh S; Ghadimi R; Mashayekh-Amiri S; Delavar MA; Basirat Z
    Minerva Obstet Gynecol; 2023 Aug; 75(4):357-364. PubMed ID: 35686634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intermittent oral iron supplementation during pregnancy.
    Peña-Rosas JP; De-Regil LM; Gomez Malave H; Flores-Urrutia MC; Dowswell T
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD009997. PubMed ID: 26482110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of antenatal dietary myo-inositol supplementation on the incidence of gestational diabetes mellitus and fetal outcome: protocol for a double-blind randomised controlled trial.
    Ibrahim I; Abdullahi H; Fagier Y; Ortashi O; Terrangera A; Okunoye G
    BMJ Open; 2022 Jan; 12(1):e055314. PubMed ID: 34983771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myo-inositol lowers the risk of developing gestational diabetic mellitus in pregnancies: A systematic review and meta-analysis of randomized controlled trials with trial sequential analysis.
    Guo X; Guo S; Miao Z; Li Z; Zhang H
    J Diabetes Complications; 2018 Mar; 32(3):342-348. PubMed ID: 29325728
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Godfrey KM; Barton SJ; El-Heis S; Kenealy T; Nield H; Baker PN; Chong YS; Cutfield W; Chan SY;
    Diabetes Care; 2021 May; 44(5):1091-1099. PubMed ID: 33782086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inositol for the prevention of gestational diabetes: a systematic review and meta-analysis of randomized controlled trials.
    Vitagliano A; Saccone G; Cosmi E; Visentin S; Dessole F; Ambrosini G; Berghella V
    Arch Gynecol Obstet; 2019 Jan; 299(1):55-68. PubMed ID: 30564926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of Myo-inositol on Type 1 Retinopathy of Prematurity Among Preterm Infants <28 Weeks' Gestational Age: A Randomized Clinical Trial.
    Phelps DL; Watterberg KL; Nolen TL; Cole CA; Cotten CM; Oh W; Poindexter BB; Zaterka-Baxter KM; Das A; Lacy CB; Scorsone AM; Walsh MC; Bell EF; Kennedy KA; Schibler K; Sokol GM; Laughon MM; Lakshminrusimha S; Truog WE; Garg M; Carlo WA; Laptook AR; Van Meurs KP; Carlton DP; Graf A; DeMauro SB; Brion LP; Shankaran S; Orge FH; Olson RJ; Mintz-Hittner H; Yang MB; Haider KM; Wallace DK; Chung M; Hug D; Tsui I; Cogen MS; Donahue JP; Gaynon M; Hutchinson AK; Bremer DL; Quinn G; He YG; Lucas WR; Winter TW; Kicklighter SD; Kumar K; Chess PR; Colaizy TT; Hibbs AM; Ambalavanan N; Harmon HM; McGowan EC; Higgins RD;
    JAMA; 2018 Oct; 320(16):1649-1658. PubMed ID: 30357297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial.
    Rizzo P; Raffone E; Benedetto V
    Eur Rev Med Pharmacol Sci; 2010 Jun; 14(6):555-61. PubMed ID: 20712264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary supplementation for gestational diabetes prevention and management: a meta-analysis of randomized controlled trials.
    Chan KY; Wong MMH; Pang SSH; Lo KKH
    Arch Gynecol Obstet; 2021 Jun; 303(6):1381-1391. PubMed ID: 33745021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of inositol supplementation in a cohort of mothers at risk of producing an NTD pregnancy.
    Cavalli P; Tonni G; Grosso E; Poggiani C
    Birth Defects Res A Clin Mol Teratol; 2011 Nov; 91(11):962-5. PubMed ID: 21956977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inositol for the prevention of neural tube defects: a pilot randomised controlled trial.
    Greene ND; Leung KY; Gay V; Burren K; Mills K; Chitty LS; Copp AJ
    Br J Nutr; 2016 Mar; 115(6):974-83. PubMed ID: 26847388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple micronutrient powders for home (point-of-use) fortification of foods in pregnant women.
    Suchdev PS; Peña-Rosas JP; De-Regil LM
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011158. PubMed ID: 26091836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial.
    Costantino D; Minozzi G; Minozzi E; Guaraldi C
    Eur Rev Med Pharmacol Sci; 2009; 13(2):105-10. PubMed ID: 19499845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of myo-inositol supplementation on ICSI outcomes among poor ovarian responder patients: A randomized controlled trial.
    Nazari L; Salehpour S; Hosseini S; Saharkhiz N; Azizi E; Hashemi T; Ghodssi-Ghassemabadi R
    J Gynecol Obstet Hum Reprod; 2020 May; 49(5):101698. PubMed ID: 32018040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of inositol stereoisomers at different dosages in gestational diabetes: an open-label, parallel, randomized controlled trial.
    Fraticelli F; Celentano C; Zecca IA; Di Vieste G; Pintaudi B; Liberati M; Franzago M; Di Nicola M; Vitacolonna E
    Acta Diabetol; 2018 Aug; 55(8):805-812. PubMed ID: 29774465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.